Pharmacogenomics and Personalized Medicine
The practices of personalized medicine are to maximize the therapeutic effects of likelihood and to minimize the risk of drug toxicity for an individual patient. Pharmacogenomics is the study of the genome in drug response. The genetic disorder occurrence is quite rare in population; some might be hereditary while the others are caused by mutations. Disease-specific epigenetic signatures such as DNA methylation, hydroxymethylation, and non-coding RNAs are now being utilized clinically for prognostics and diagnostics, while an expanding collection of genetically aberrant, abnormally expressed or chromatin-interacting epigenetic enzymes are positioned as promising targets for therapeutic intervention. Scientists also recognize that even as the knowledge base continues to expand, the clinical translation of that knowledge still requires empirical evidence, generated for a particular disease and drug combination, before treatment can be customized to a patient's genotype.
- Genomic DNA and mRNA
- Serotonin transporter gene
Related Conference of Pharmacogenomics and Personalized Medicine
17th International Conference on Genomics & Pharmacogenomics
14th International Conference and Exhibition on Advanced Cell and Gene Therapy
17th International Conference on Genomics and Molecular Biology
14th International Conference on Human Genetics and Genetic Diseases
Pharmacogenomics and Personalized Medicine Conference Speakers
Recommended Sessions
- Animal Epigenetics
- Autoimmune Diseases
- Blood Diseases
- Cancer Epigenetics
- Cardiovascular Diseases
- Chromatin and chromosome dynamics
- Chronic Diseases
- Clinical Epigenetics
- Depression and Mental illness
- Epigenetics Biomarkers
- Epigenetics Therapy
- Gynecological and Obstetrical Diseases
- Infectious Diseases
- Kidney Diseases
- Liver Diseases
- Molecular Diagnostics of Human Diseases
- Neurodegenerative Diseases
- Pharmacogenomics and Personalized Medicine
- Plant Epigenetics
- Rare Diseases
Related Journals
Are you interested in
- Animal Genetics - Genome 2023 (USA)
- Biochemical Genetics - Human Genetics 2024 (Canada)
- Bioinformatics and Computational Biology - Genome 2023 (USA)
- Bioinformatics, Machine learning and Statistical methods - HUMAN GENETICS MEET 2024 (UAE)
- Biomarkers and Microarrays - Genome 2023 (USA)
- Cancer Genetics - Human Genetics 2024 (Canada)
- Cancer Genomics - Genome 2023 (USA)
- Cancer, Cardiovascular Diseases and Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Clinical Genetics - Human Genetics 2024 (Canada)
- Clinical Genetics and Novel Therapies of Genetic Diseases - HUMAN GENETICS MEET 2024 (UAE)
- Clinical genomics - Genome 2023 (USA)
- Comparative Genomics - Genome 2023 (USA)
- Cytogenetics - Human Genetics 2024 (Canada)
- Developmental Genetics - Human Genetics 2024 (Canada)
- Epigenetics - Human Genetics 2024 (Canada)
- Epigenetics and Gene Regulation - HUMAN GENETICS MEET 2024 (UAE)
- Epigenomics and Epigenetics - Genome 2023 (USA)
- Ethical & Social Implications of Gene Editing - Human Genetics 2024 (Canada)
- Evolutionary and Population Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Functional Genomics - Genome 2023 (USA)
- Functional Genomics and Transcriptomics - HUMAN GENETICS MEET 2024 (UAE)
- Gene Cloning and Mapping - HUMAN GENETICS MEET 2024 (UAE)
- Gene Editing and Genetic Engineering - Genome 2023 (USA)
- Gene Therapy - Human Genetics 2024 (Canada)
- Gene Therapy and Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Disorder - Genome 2023 (USA)
- Genetic Disorders - Human Genetics 2024 (Canada)
- Genomic Instability - Genome 2023 (USA)
- Genomic Medicine - Genome 2023 (USA)
- Genomic Medicine & Molecular Diagnostics - Human Genetics 2024 (Canada)
- Genomics - Human Genetics 2024 (Canada)
- Human Genetic Engineering - Human Genetics 2024 (Canada)
- Human Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Human genetics - Human Genetics 2024 (Canada)
- Immunogenetics - Human Genetics 2024 (Canada)
- Medical Genetics - Human Genetics 2024 (Canada)
- Microbial Genomics - Genome 2023 (USA)
- Molecular and Cytogenetics - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Effects of Genetic Variation - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Genetics - Human Genetics 2024 (Canada)
- Molecular Phenotyping and Omics Technologies - HUMAN GENETICS MEET 2024 (UAE)
- Mutation Detection and Analysis - HUMAN GENETICS MEET 2024 (UAE)
- Next generation sequencing - Genome 2023 (USA)
- Nutrigenomics - Genome 2023 (USA)
- Nutritional Genomics - Human Genetics 2024 (Canada)
- Oncogenomics and Cancer Heredity - Human Genetics 2024 (Canada)
- Personalized and Regenerative Medicine - Genome 2023 (USA)
- Pharmacogenetics - Human Genetics 2024 (Canada)
- Pharmacogenomics - Genome 2023 (USA)
- Pharmacogenomics - HUMAN GENETICS MEET 2024 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2023 (USA)
- Population Genetics - Human Genetics 2024 (Canada)
- Sickle cell Anaemia Genomics - HUMAN GENETICS MEET 2024 (UAE)
- Stem Cell Research - Human Genetics 2024 (Canada)
- Stem Cell Research and Therapy - Human Genetics 2024 (Canada)
- Stem cell Transplantation - HUMAN GENETICS MEET 2024 (UAE)
- Structural Genomics - Genome 2023 (USA)
- Translational Medicine - HUMAN GENETICS MEET 2024 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2023 (USA)